Conclusions:
Overall, patients with CU were highly interested in using an app to
assess their disease activity and control. Development of well-designed
apps, specific to disease types (CSU, CIndU, CSU+CIndU, etc), validated
by experts across platforms would help improve the management and
possibly outcomes of CU treatment while providing important patient
information to be used in future research.